Snake Venom Topical Analgesic Matrix with Permeation Enhancers
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current analgesic and anti-inflammatory treatments for neuropathy, arthritis, and muscular/joint pain often lack effective topical solutions that combine synergistic natural substances with transdermal drug permeation enhancers, limiting their efficacy and safety.
Innovation Solution
A novel topical analgesic product combining synergistic snake venoms from Indian cobra, timber rattlesnake, South American Bushmaster, and Mojave rattlesnake with transdermal permeation enhancers and natural anti-inflammatory agents, stabilized by a custom matrix, to enhance analgesic effects while minimizing toxic properties.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If snake venom is used as an analgesic substance, then pain relief effect is improved, but toxic properties increase
Solution Approach 1:
The patent applies this principle by using snake venom components that are naturally toxic but processing them through specific purification and formulation methods to convert the harmful toxic properties into beneficial analgesic effects. The venom is processed to retain pain-relieving components while removing or neutralizing toxic elements, effectively transforming a harmful substance into a therapeutic agent.
Solution Approach 2:
The patent changes the concentration parameters of venom components in the formulation. By carefully controlling and optimizing the concentration of snake venom peptides and proteins within specific ranges, the formulation achieves effective analgesic action while maintaining safety margins that prevent toxic effects. This parameter optimization allows the same substance to be both effective and safe.
2Reliability
If multiple snake venoms are combined, then synergistic analgesic effect is improved, but formulation complexity increases
Solution Approach 1:
The patent merges multiple snake venom components from different venom sources into a single integrated topical formulation. By combining peptides and proteins from various snake venoms that target different pain pathways, the formulation achieves synergistic analgesic effects. The merging process is simplified through a standardized base formulation that accommodates multiple venom components without requiring separate complex delivery systems.
3Productivity
If transdermal permeation enhancers are added, then drug delivery efficiency is improved, but skin irritation risk increases
Solution Approach 1:
The patent optimizes the concentration parameters of transdermal permeation enhancers within specific ranges. By carefully controlling the amount of penetration enhancers and adjusting other formulation parameters such as pH and vehicle composition, the formulation achieves effective transdermal delivery of snake venom components while maintaining skin tolerance and minimizing irritation risks.
Solution Approach 2:
The patent uses the topical formulation vehicle as an intermediary medium that facilitates the controlled delivery of both snake venom components and permeation enhancers. This intermediary system ensures that the enhancers are delivered in a controlled manner that maximizes penetration efficiency while minimizing direct skin contact irritation, acting as a buffer between the active ingredients and the skin.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The product demonstrates significant pain relief in clinical studies, reducing muscle and joint pain by 32.14% and 29.40% respectively, with no adverse events, showcasing enhanced analgesic and anti-inflammatory effects through synergistic action and improved transdermal delivery.
Implementation Method 1
combines these multiple interactions, in the case of topical administration, with a similar, synergistic combination of transdermal drug permeation enhancers
Data Source
AI summary
A homeopathic pain topical analgesic composition based on snake venom is disclosed. The study product also contained of Arnica montana, a homeopathic remedy most frequently used for fractures, bruises, and muscle strains due to its analgesic and anti-inflammatory effects. The composition also contained a penetrant component to enhance penetration of the ingredients as well as an analgesic/anti-inflammatory component. The snake venoms used may include those of Naja naja, Crotalus horridus and Lachesis muta. A clinical study of a product formulated in this way was effective in promoting relief from muscle pain and discomfort.